The desperate need for medical isotopes

With preparations underway for manufacturing the MIFTEC Z-pinch (ZEBRA) Fusion Medical Isotope Generators, US Nuclear Corp. (OTCBB: UCLE) is one step closer to ending the dire worldwide shortage of medical isotopes.  The federal government is so desperate to find a domestic, stable supply of medical isotopes that they recently awarded over $60 million in funding to 8 projects/companies working on solutions for this demand.  Of these 8 companies, only 3 have timelines to supply medical isotopes in the near future, and of those 3, Magneto-Inertial Fusion Technologies, Inc (MIFTI, parent company to MIFTEC) has the most promising solution.  MIFTEC’s patented fusion-powered medical isotope generator can not only solve the medical isotope shortage, but the revolutionary process also offers numerous advantages to current production methods, including:

• MIFTEC’s process is fueled by a simple isotope of hydrogen from a renewable source: seawater.
  Current production methods of medical isotopes are fission-based nuclear reactors or accelerators that require either highly enriched or low enriched uranium (HEU/LEU) to operate. These methods are costly, multi-step processes that result in nuclear waste byproducts that must be safely contained and stored for hundreds of years while being protected from theft by terrorists.
• Due to the eco-friendly, fusion-based technology, the capital and operational costs are a fraction of that for fission or accelerator technology.  Additionally, medical isotope production costs are up to 50% less than all other current manufacturing processes.
• The device is designed to fit into most hospitals, nuclear medicine clinics, and laboratories.  It is ideal for local, domestic production, and results in a major reduction in transportation and import costs.  Local production also solves the timeline issues of Mo-99’s 66-hour half-life.
• No production limit problem.  Current methods to build a nuclear reactor or accelerator are time-consuming and expensive, and once finally built, these facilities have a maximum production limit.  There is currently around a $5 billion shortfall in medical isotope production. US Nuclear can build MIFTEC’s medical isotope generators in a fraction of the time and cost, with the production line continuing until demand has been filled.